Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03630419 · ClinicalTrials.gov registry record · Phase 1
Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients
A Phase 1 study, sponsored by Perseverance Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT03630419: Completed Phase 1 study, sponsored by Perseverance Research Center.
NCT03630419 is a Phase 1 study that has completed, run by Perseverance Research Center. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03630419, a Phase 1 study, has completed, sponsored by Perseverance Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Diet plays a large role in inflammation, oxidative stress and cognition; however, every person's body type, resting metabolic rate, BMI, and inflammation levels vary. Through performing physiological and comprehensive cellular testing through bio-impedance, allows this study to create personalized diet plans for each subject's body type. Cellular repair therapy has also been known to improve cellular health and inflammation. Through decreasing inflammation and improving oxidative stress, cognition in those with MCI and AD could improve.
Primary Outcome
Mito-Food plan with cellular repair therapy will decrease inflammation in MCI and AD patients
Interventions
- DIETARY_SUPPLEMENT Mito-Food Plan
- OTHER Cellular Repair Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-02-10 |
| Est. Completion | 2018-07-28 |
| Phase | Phase 1 |
What the finished NCT03630419 record still lists
NCT03630419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Mito-Food Plan is the first listed.
NCT03630419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03630419 about?
NCT03630419 is a clinical study titled "Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients". Diet plays a large role in inflammation, oxidative stress and cognition; however, every person's body type, resting metabolic rate, BMI, and inflammation levels vary. Through performing physiological and comprehensive cellular testing through bio-impedance, allows this study to create personalized d...
What is the current status of trial NCT03630419?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2018-02-10. Estimated completion is 2018-07-28.
What interventions are being tested in trial NCT03630419?
The interventions under investigation include: Mito-Food Plan (DIETARY_SUPPLEMENT), Cellular Repair Therapy (OTHER).
Who is sponsoring clinical trial NCT03630419?
This trial is sponsored by Perseverance Research Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03630419's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI